Browsing by Author "Pineda, Estela"

Sort by: Order: Results:

  • Esteve-Codina, Anna; Arpí Llucià, Oriol; Martínez-García, Maria; Pineda, Estela; Mallo, Mar; Gut, Marta; Carrato, Cristina; Rovira Guerín, Ana; Lopez, Raquel; Tortosa, Avelina; Dabad, Marc; del Barco, Sonia; Heath, Simon; Bagué, Silvia; Ribalta, Teresa; Alameda Quitllet, Francisco; de la Iglesia, Nuria; Balaña, Carmen; GLIOCAT Group (Public Library of Science (PLoS), 2017)
    The molecular classification of glioblastoma (GBM) based on gene expression might better explain outcome and response to treatment than clinical factors. Whole transcriptome sequencing using next-generation sequencing ...
  • Hernandez, Ainhoa; Muñoz-Mármol, Ana M.; Esteve-Codina, Anna; Alameda Quitllet, Francisco; Carrato, Cristina; Pineda, Estela; Arpí Llucià, Oriol; Martinez-García, Maria; Mallo, Mar; Gut, Marta; Barco Berrón, Sonia del; Gallego, Oscar; Dabad, Marc; Mesia, Carlos; Bellosillo Paricio, Beatriz; Domenech, Marta; Vidal, Noemí; Aldecoa, Iban; Iglesia, Nuria de la; Balana, Carmen (Nature Research, 2022)
    RNA-Sequencing (RNA-Seq) can identify gene fusions in tumors, but not all these fusions have functional consequences. Using multiple data bases, we have performed an in silico analysis of fusions detected by RNA-Seq in ...
  • Pedrosa, Leire; Bedia, Carmen; Diao, Diouldé; Mosteiro, Alejandra; Ferrés, Abel; Stanzani, Elisabetta; Martínez-Soler, Fina; Tortosa, Avelina; Pineda, Estela; Aldecoa, Iban; Centellas, Marc; Muñoz-Tudurí, Marta; Sevilla, Ana; Sierra, Àngels; González Sánchez, José Juan (MDPI, 2023)
    Background: The high recurrence of glioblastoma (GB) that occurs adjacent to the resection cavity within two years of diagnosis urges an improvement of therapies oriented to GB local control. Photodynamic therapy (PDT) has ...
  • Martínez-García, Maria; Velasco, Guillermo; Pineda, Estela; Gil-Gil, Miguel J.; Alameda Quitllet, Francisco; Capellades Font, Jaume; Martín-Soberón, Mari Cruz; López-Valero, Israel; Tovar Ambel, Elena; Foro Arnalot, Palmira; Taus García, Álvaro; Arumí Uría, Montserrat; Hernández-Laín, Aurelio; Sepúlveda-Sánchez, Juan Manuel (MDPI, 2022)
    Background: MET-signaling and midkine (ALK ligand) promote glioma cell maintenance and resistance against anticancer therapies. ALK and c-MET inhibition with crizotinib have a preclinical therapeutic rationale to be tested ...
  • López-Rueda, Antonio; Puig, Josep; Thió-Henestrosa, Santiago; Moreno-Negrete, Javier Luis; Zwanzger, Christian; Pujol, Teresa; Aldecoa, Iban; Pineda, Estela; Valduvieco, Izaskun; González, José Juan; Oleaga, Laura (MDPI, 2023)
    Purpose: Glioblastoma often recurs after treatment. Bevacizumab increases progression-free survival in some patients with recurrent glioblastoma. Identifying pretreatment predictors of survival can help clinical decision ...
  • Gorria, Teresa; Crous-Bou, Marta; Pineda, Estela; Hernandez, Ainhoa; Domenech, Marta; Sanz, Carolina; Jares, Pedro; Muñoz Mármol, Ana María; Arpí Llucià, Oriol; Meléndez, Bárbara; Gut, Marta; Esteve, Anna; Esteve-Codina, Anna; Parra Farré, Genís; Alameda Quitllet, Francisco; Carrato, Cristina; Aldecoa, Iban; Mallo, Mar; Iglesia, Nuria de la; Balana, Carmen (MDPI, 2024)
    The aim of this study was to determine how TERTp mutations impact glioblastoma prognosis. Materials and methods: TERTp mutations were assessed in a retrospective cohort of 258 uniformly treated glioblastoma patients. ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking